Stock listing

Cardiol Therapeutics Inc. Class A (CT9) Stock Price, News, Filings & Events

Selected listing: CT9 · GETTEX · EUR · DE

CT9:GETTEX is the listing for Cardiol Therapeutics Inc. Class A, a Canadian public company dedicated to developing innovative therapies for cardiovascular diseases. With a market capitalization of approximately €122.3 million, Cardiol is focused on addressing significant unmet medical needs through its research and development initiatives. The company continues to advance its projects and engage with the market, reflecting its commitment to improving cardiovascular health.

websiteCT9:GETTEXEURDESEO content: aiUpdated June 24, 2026/stock/gettex-ct9/cardiol-therapeutics-inc-class-a/l-9aqaidlrfx
Cardiol Therapeutics Inc. Class A logo
Ticker
CT9:GETTEX
Asset type
Stock
Market cap
$122.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Cardiol Therapeutics Inc. Class A CT9:GETTEX stock context

CT9:GETTEX is the listing for Cardiol Therapeutics Inc. Class A, a Canadian public company dedicated to developing innovative therapies for cardiovascular diseases. With a market capitalization of approximately €122.3 million, Cardiol is focused on addressing significant unmet medical needs through its research and development initiatives. The company continues to advance its projects and engage with the market, reflecting its commitment to improving cardiovascular health.

Research Cardiol Therapeutics Inc. Class A

Alternate listings